Evidence map›Paper›PMID 41674764›Full record

ArticleCureus2026

Phenotyping Dysautonomia in Unexplained Syncope: Diagnostic Yield and Therapeutic Implications in a Moroccan Cohort.

Oumaima Taoussi, Hibat Allah Kamri, Soukaina Scadi, Benouna Ghali, Fatimazahra Merzouk

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oumaima TaoussiCardiology, Mohammed VI International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Hibat Allah KamriCardiology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Soukaina ScadiCardiology, Mohammed VI International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Benouna GhaliCardiology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.
Fatimazahra MerzoukCardiology, Mohammed VI International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective Unexplained syncope remains a frequent and challenging clinical problem, even after guideline-directed cardiovascular and neurological evaluation. In a substantial proportion of patients, syncope remains without an identified etiology after conventional investigations, suggesting alternative underlying mechanisms. Autonomic nervous system (ANS) dysfunction plays a central role in cardiovascular regulation and has been increasingly recognized as a key contributor to unexplained syncope. ANS testing allows objective evaluation of cardiovascular autonomic reflexes, including sympathetic and parasympathetic responses to orthostatic and physiological stressors. The objective of this study was to assess autonomic profiles using standardized ANS testing in patients referred for unexplained syncope and to characterize dysautonomic patterns that may contribute to syncope mechanisms. Methods We conducted a retrospective mono-centric study including 90 consecutive adult patients referred to a tertiary autonomic unit for syncope remaining without an identified etiology after conventional evaluation between January 2024 and June 2025. All patients underwent a standardized ANS testing battery, including an active standing (orthostatic) test, a deep-breathing test, an isometric handgrip test, and a mental stress test. Demographic data, cardiovascular risk factors, clinical presentation, and ANS test results were systematically collected and analyzed. Results ANS testing identified autonomic abnormalities considered clinically relevant in a high proportion of patients with unexplained syncope despite routine conventional investigations. The most frequent findings included exaggerated vagal responses, orthostatic intolerance syndromes such as postural orthostatic tachycardia syndrome, sympathetic alpha-adrenergic dysfunction leading to orthostatic hypotension, and mixed autonomic profiles. Overlapping autonomic phenotypes were frequently observed within the same patient, underscoring the complexity of dysautonomic syncope. Conclusion ANS testing provides a high diagnostic yield in patients with syncope remaining without an identified etiology after standard evaluation by revealing clinically relevant autonomic dysregulation. Integration of ANS testing as a second-line diagnostic approach may improve etiological classification and support individualized management strategies in selected patients.

Indexed as

autonomic nervous system testingdysautonomiaorthostatic hypotensionpostural orthostatic tachycardia syndromeunexplained syncope

Identifiers

PMID41674764
PMCPMC12887543

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.